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ABSTRACT 
Oral films are gaining a lot of attention as a substitute approach to the conventional dosage form. Over the past few years, many of the 
pharmaceutical scientists throughout the world are focusing their research on oral films, trying to see the sights of oral films as a novel drug 
delivery system. The oral films are convenient to swallow for geriatric and pediatric patients, are self-administrable, used for systemic and local 
action and rapid release of a drug, which makes it an excellent system of drug delivery. This review article mainly discusses the manufacturing 
aspects of films and their characterization, applications and the constraints in the development of oral films along with highlights of market 
potential. 
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An oral film as drug delivery is emerging as an advanced alternative to 
the traditional oral methods of drug administration. Oral film delivery 
system is a solid dosage form which dissolves in a short span when 
administered without chewing or drinking water. Oral films containing 
active drugs are designed for oral administration, allowing the drug to 
bypass the first pass metabolism in the liver thus enhancing the 
bioavailability. Upon dissolution, medication enters bloodstream 
enterically, buccally and sublingually. Making an oral film involves the 
use of a hydrophilic polymer as a vital ingredient that rapidly dissolves 
in the buccal cavity thus delivering medication into systemic 
circulation. This advanced innovation in the formulation was first 
invented by Richard and Joseph Fuisz, Garry Myers and Robert Yang. 
They have contributed over 30 patents in this field [1]. The most 
favoured route of drug administration is oral route due to cost 
efficiency and ease of administration which lead to high patient 
compliance for the pediatric and geriatric group, but it is still 
challenging route due to swallowing difficulty for pediatric and 
geriatric patients. The development of novel and safer drug delivery 
such as oral strips, buccal films are the result of patient convenience 
and compliance-oriented research. In recent times, an oral film drug 
delivery system has gained lots of popularity and acceptance [1, 2]. 
Oral film technology was first invented in the late 1970s just to 
overcome swallowing difficulties related to tablets and capsules faced 
by geriatric and pediatric patients but now is trending in pharma 
industry due to less fragility than other oral dosage forms, dosage 
accuracy, rapid release, ease of administration. These oral films are 
also known as oral strips, buccal strips or films. A variety of 
bioadhesive mucosal dosage form has been developed such as 
adhesive tablets, gels, ointments, patches and currently polymeric film 
for buccal delivery is known as mouth dissolving films. Oral films have 
a shelf life of 2-3 y depending upon the active pharmaceutical 
ingredient but are unusually sensitive to environmental moisture [3]. 
The following review was focused on elaborating the manufacturing 
aspects of films and their characterization, market potential, 
applications and the constraints in development of oral films. Review 
and research article on oral films and its market potential that are 
available in journal databases such as Science Direct, PubMed, 
Springer, Pharmatutor from the year 2000-2017 were studied and in-
depth knowledge of oral films in present market was produced. Very 
few articles before the year 2000 were also considered. 
Keywords used to search: formulation, methods of preparation, 
market potential, patented oral films. 
An ideal oral film possesses following properties such as high 
stability, transportability, ease of handling and administration, no 
water necessary for application and pleasant taste. Therefore, they 
are very suitable for pediatric and geriatric patients, bedridden 
patients; or patients suffering from dysphagia, Parkinson's disease, 
mucositis or vomiting. Oral films were first introduced to the market 
as breath fresheners and personal care products such as dental care 
strips and soap strips. These oral dosage forms were introduced in 
the United States and European pharmaceutical markets for 
therapeutic benefits. The first oral strip was developed by Pfizer 
named as Listerine pocket packs which were used as mouth 
freshener [1]. 
Advantages 
• Pleasing and fresh mouthfeel. 
• No risk of choking. 
• Easy application-no swallowing and chewing difficulties. 
• To avoid first pass metabolism. 
• Administering of an accurate dose is possible. 
• For improved patient compliance, small size is available. 
• Rapid onset of action. 
• It helps in enhancing stability [4]. 
• It masks the bitter taste. 
• Available in various sizes and shapes.  
• Reduce gastrointestinal irritation. 
Disadvantages  
• Sometimes show the fragile and granular property. 
• Hygroscopic in nature thus must be stored in a dry place. 
• Require special packaging for the product stability and safety. 
• The high dose cannot be incorporated into an oral film. 
• Eating and drinking may be restricted. 
• Drug unstable at buccal pH cannot be administered. 
• A drug with nauseous odour cannot be administered [5] 
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Table 1: Comparison between oral films and oral tablets 
Oral films Oral tablets Reference 
Oral films have greater dissolution due to large surface area Oral tablets have lesser dissolution area as compared to oral films 6 
They have better longevity than oral tablets They have less longevity than oral films 7 
They have more patient compliance than oral tablets They have less patient compliance as compared to oral film  
There is no risk of choking There can be the risk of choking  
In oral films, an only low dose can be incorporated In oral tablets, the high dose can be incorporated  
 
Comparison between oral films and oral tablets 
Classification of oral films 
There are three different subtypes of oral films- 
1. Mucoadhesive sustained release wafer 
2. Mucoadhesive melt away wafer 
3. Flash release 
Formulation of oral films 
The typical composition of oral films comprises of: 
 
Table 2: Classification of oral films [8-10] 
Subtypes Mucoadhesive sustained 
release wafer 
Flash release Mucoadhesive melt away wafer Reference 
Thickness (µm) 50-250 7-20 50-500  
Area (sq. cm) 2-4 2-8 2-7  




Structure Multilayer system Single layer system A single layer or multilayer system  
The site of action Local or systemic Local or systemic Local or systemic  
Excipients Low/non-soluble polymers Soluble, highly hydrophilic 
polymers 
Soluble, highly hydrophilic polymers 9 
Dissolution Maximum 8-10 h. Minimum 60 sec. 
Maximum 8-10 h. 
Disintegrate in a few mins, forming 
the gel 
 
Application The gingival and another region 
in an oral cavity 
Tongue (upper palate) Gingival or buccal region 10 
 
Table 3: Composition of an oral film 
Constituents Quantity Reference 
Drug 5%-30% w/w 11 
Polymer 45% w/w 12 
Plasticizers 1%-20% w/w  
Saliva stimulating agent 2%-6% w/w 13 
Surfactants q. s.  
Colouring agent q. s.  
Sweetening agent 3%-6% w/w  
Flavoring agent q. s.  
Other agents q. s.  
 
Components of oral film 
Active pharmaceutical ingredient 
The variety of active pharmaceutical ingredients can be administered. 
Since there is a limitation for the size of the dosage form, high dose drugs 
are difficult to incorporate into the film. For oral films, ideal active 
pharmaceutical ingredient (API) preferred should be less bitter, potent 
and highly lipophilic. The medication incorporated into the film is about 
5% w/w to 30%w/w of the dry film, and for multivitamin up, to 10% 
w/w of the dry film can be incorporated [14]. 
The ideal characteristics of an Active Pharmaceutical Ingredient are:  
• Drug to be incorporated should have low dose up to 40 mg 
• Drugs with smaller and moderate molecular weight are preferred 
• The drug should be stable and soluble in water and saliva 
• The drug should be partially unionized at pH of the oral cavity 
• A drug should be able to permeate through the oral mucosa. 
Special classes of active pharmaceutical ingredient (API) that can be 
administered are local anesthetics, anti-migraine drugs, and drugs 
for a sore throat, multivitamins, and melatonin. Other types of drugs 
are antiallergic, antihistaminic, analgesic, smoking cessations, 
bronchodilators, nootropic agents, etc [15]. 
Film forming polymers 
The varieties of polymers are accessible for a formulation of oral 
films. One of the most critical and essential factors for the selection 
of polymer to formulate oral film is that it should disintegrate in 
seconds. The polymers improve the flexibility, hydrophilicity, 
mouthfeel, and solubility of the oral film. The amount of polymer 
present in the formulation decides the stiffness and robustness of 
the film. The amount of polymers used alone or in combination is 
about 45%w/w. The polymers used for formulating oral films 
should be water soluble, low molecular weight and an excellent film 
forming capacity. The water-soluble polymers are used as they 
provide rapid disintegration, good mouth feels and excellent 
mechanical strength to film. The water-soluble polymers used are 
pullulan, gelatin, guar gum, xanthan gum, modified starch, PVA, 
HPMC PVP K30, etc [16]. 
Out of these polymers, HPMC and Pullulan are the commonly used 
polymers for the formulation of oral films. HPMC is the propylene 
glycol ether of methylcellulose. In preparation of the oral film, low 
viscosity grades of HPMC such as HPMC E3/E5/E6/E15 are used. 
Pullulan is a neutral glucan (like amylose, dextran, and cellulose) 
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with a chemical structure depending on the carbon source, 
producing microorganism (different strains of Aureo-
basidiumpullulans) and fermentation conditions [17]. 
Plasticizers 
A plasticizer is a crucial ingredient of the oral film. The choice of 
plasticizer depends upon its compatibility with the polymer and the 
type of solvent used in the casting of the film. It reduces the 
brittleness of the film and improves the flexibility of the film. It 
enhances the film properties by lowering the glass transition 
temperature of the polymer. It lowers the glass transition 
temperature of the polymer to 40-60 degree Celsius for the non-
aqueous solvent system and below 75 degree Celsius for the 
aqueous solvent system [18]. They should be volatile in nature. The 
concentration of plasticizer used is 1%w/w to 20%w/w of dry 
polymer. Plasticizers enhance mechanical properties such as tensile 
strength and elongation to the film by dropping the glass transition 
temperature of the polymer. It also reduces the brittleness of the 
film by setting itself between the polymer chains acting as a hinge to 
the support thus improving the flexibility of the film. The commonly 
utilized plasticizers are phthalate derivatives like diethyl, methyl, 
and dibutyl phthalate, cellulosic hydrophilic polymers plasticized 
with OH containing PEG, propylene glycol, polyol, less cellulosic 
hydrophilic polymers plasticized with esters of citric acid, phthalic 
acid, diethyl glycol and glycerol [18]. The phthalates are not used 
currently in the formulation as it shows carcinogenicity. Inaccurate 
utilization of plasticizer may cause blooming, crack, peeling and split 
of films [19]. 
Saliva stimulating agents 
Saliva stimulating agents are utilized to boost the rate of saliva 
production which aids in a faster disintegration of the oral film 
formulations. The formulations may contain acids which are used as 
salivary stimulants. Citric acid, malic acid, lactic acid, ascorbic acid, 
lactic acid and tartaric acid [9]. Citric acid is the most preferred 
among them. Sometimes sweeteners are also used as salivary 
stimulants. The concentration of saliva stimulating agents used is 
2%w/w to 6% w/w. They can be used alone or in combination [20]. 
Sweetening agents 
Sweeteners have become the essential part of the food products and 
pharmaceutical products intended to be disintegrated or dissolved 
in the oral cavity [21]. They are used in the concentration of 3%w/w 
to 6%w/w. Natural and artificial sweeteners are used to improve the 
palatability of the oral film formulations. Some suitable sweeteners 
include- 
• Water-soluble natural sweetener: xylose, ribose, sucrose, 
maltose, fructose, stevioside etc. 
• Water-soluble artificial sweetener: sodium or calcium saccharin 
salts, acesulfame-k salts, cyclamate etc. 
• Dipeptide based sweetener: aspartame 
• Protein-based sweetener: thaumatin I and II 
• Polyhydric alcohols: sorbitol, mannitol, isomalt, maltitol 
Polyhydric alcohols, if used in combination, provide good mouthfeel 
and cooling sensation. Fructose is sweeter than sorbitol and 
mannitol thus commonly used as a sweetener. Neotame and alitame 
are 2000-8000 times sweeter than sucrose [22]. 
Cooling agents 
Cooling agents are added to boost the flavour and to improve the fresh 
mouthfeel the effect of the oral film. Some cooling agents are WS23, 
WS3, and Utracoll II which are used with a blend of flavours [13]. 
Flavouring agents 
Flavouring agents are used to mask the bitter taste of drug and to 
add some zest to the formulation. The choice of the flavours varies 
from person to person depending on the ethnicity and taste [9]. 
Flavouring agents can be acquired from oleoresins extract, synthetic 
flavour oils derived from different parts of the plant like leaves, 
fruits and flowers. The amount of flavor needed to mask the taste of 
medication depends on the flavour type and strength. Flavouring 
agents utilized are peppermint, cinnamon, nutmeg, vanilla, cocoa, 
chocolate, coffee, citrus, apple, etc [13]. 
Colouring agent 
Colouring agents are utilized to impart colour to the formulation to 
make it eye pleasing. Pigments like titanium dioxide or food, drug 
and cosmetic (FD and C) act approved colouring agents are 
incorporated in an oral film when some of the formulation 
ingredients or drugs are present in suspension or insoluble form. 
The concentration of the colouring agents should not exceed the 
level of 1% w/w [13]. 
Surfactants 
Surfactants are utilized as solubilizing or wetting or dispersing 
agents which are used to dissolve the film within seconds and to 
release medication instantly. They are also used to improve the 
solubility of poorly soluble drugs in oral films. Surfactants used are 
poloxamer 407, benzalkonium chloride, benzethonium chloride, 
tweens, spans and sodium lauryl sulphate [23]. 
Stabilizing and thickening agent 
These agents are engaged in improving the viscosity and consistency 
of dispersion or solution of film preparation before casting. Natural 
gums like xanthan gum, carrageenan, locust bean gum and cellulosic 
derivatives are used [23]. 
Methods of preparation 
The oral films are manufactured by various approaches. 
One or in combination following techniques can be used for the 
preparation of oral films. 
Solvent casting method 
It is the pharmaceutical technique in which active pharmaceutical 
ingredient is dissolved or suspended in the solution of polymers, 
plasticizers and other different components dissolved in a volatile 
solvent like ethanol or water. This material is stated as the film dope 
which is spread out using established solvent-cast film technique on 
a constant movement of release media like plastic impregnated 
paper [19]. Initially, polymers soluble in water are dissolved in 
water at 60 degree celsius, and all different excipients like shading 
agents, sweetening agent and flavoring agents are added 
independently and later included by mixing at 1000 rpm. The 
solution is fused with the active pharmaceutical ingredient, and the 
entangled air is evacuated and cast as the film. Solvent casting is the 
best technique for manufacturing films containing heat delicate 
active pharmaceutical ingredient because the temperature required 
to expel the solvents is generally low contrasted with those needed 
for the hot melt extrusion process [24]. 
Semisolid casting method 
In semisolid casting strategy initially, the solution of water-soluble 
film-forming polymer is prepared. The obtained mixture is added to 
a solution of insoluble acid polymer (like cellulose acetate phthalate, 
cellulose acetate butyrate) which was set up in ammonium or 
sodium hydroxide [12]. To obtain a gel mass, the appropriate 
amount of plasticizer is added. Finally, utilizing heat controlled 
drums, the gel mass is cast into films or ribbons. The thickness of the 
film is maintained around 0.015-0.05 inches. The proportion of the 
insoluble acid polymer to film forming ought to be 1:4 [22]. 
Hot melt extrusion 
Hot melt extrusion is commonly employed to prepare sustained-
release tablets, granules, and transmucosal and transdermal drug 
delivery systems. In this technique, the solid mass is formed by 
blending the drug and other components [24]. The dried granular 
solid is introduced in the extruder and extrudate obtained is then 
pressed into the calendar to get a film. The ejected film is then 
cooled, cut and packed. 
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The principle drawback of hot melt extrusion (HME) is that it 
exposes the film ingredients to high temperature which causes 
thermal degradation. All the components that are utilized hot melt 
film must be deprived of water or any other volatile solvents. The 
heat used for the process can cause such contaminants to boil and 
create voids in the film, influencing its consistency, quality, strength 
and appearance [25]. 
Solid dispersion technique 
The word solid dispersion alludes to the dispersion of one or more 
active pharmaceutical ingredients in an inert carrier, in a solid state, 
in the presence of amorphous hydrophilic polymers using 
techniques like hot melt extrusion. In this technique, immiscible 
components are expelled with the drug, and then solid dispersions 
are prepared. Then with the aid of dies, the solid dispersions are cast 
into films [12, 24]. 
Rolling method 
In this technique, a film-forming solution or suspension containing 
medication is rolled on a carrier. The solvent is used mostly water or 
mixture of alcohol and water. The film formed is dried up on rollers 
and cut into desired shapes and sizes. This is the natural and cost-
effective technique for the manufacturing of oral films [12, 26]. 
Evaluation of oral films 
The various evaluation parameters for an oral film are as follows:  
Dryness/tack test 
There are about eight stages of film drying process. They are set-to-
touch, dust free, tack-free (surface dry), dry-to-touch, dry-hard, dry-
through (dry-to-handle), dry-to-recoat and dry print-free. These 
tests are primarily used to paint films, but most of the studies can be 
revised to evaluate pharmaceutical oral films. Tack is the firmness 
with which the film adheres to an adjunct (a piece of paper) that has 
been pressed into contact with the film. Various instruments are 
accessible for this investigation [4, 25]. 
Thickness 
The thickness of the film is related explicitly with drug content and 
uniformity thus it is essential to determine uniformity in the 
thickness of the film. Thickness can be estimated by micrometer 
screw gauge or calibrated digital Vernier calliper at various strategic 
locations [16, 25]. 
Percent elongation 
When stress is applied to a sample, it stretches, and this is referred 
to as strain. A strain is the deformation of the film divided by an 
original dimension of the film. Usually, elongation of the film 
increases as the plasticizer content increases [27].  
% Elongation = Increase in length/original length * 100 
Young’s modulus 
Young’s modulus or elastic modulus is the measure of rigidity or 
toughness of film. It is given as the ratio of applied stress over strain 
in the region of elastic deformation as follows:  
Young’s Modulus = force at corresponding strain/cross-sectional 
area*1/corresponding strain  
Tensile strength 
Tensile strength is the maximum stress applied to a point at which 
the oral film sample breaks. It is calculated as the applied load at 
breach divided by the cross-sectional area of the film as given in the 
equation below:  
Tensile strength = load at breakage/film thickness * film width 
Folding endurance 
Folding endurance is determined by repeated folding of the film at 
the same place till the film breaks. The number of times the film is 
folded without breaking is recorded as the folding endurance 
value [25]. 
Tear resistance 
Tear resistance of the film is a complex function of its resistance to 
rupture. The primarily minimum rate of loading 51 mm (2 in) per 
minute is employed and is designed to measure the force to initiate 
tearing. The maximum stress or strength enquired to break the sample is 
reported as the tear resistance value in Newtons (or pound-force). 
Swelling property 
Swelling property is studied by using simulated saliva solution. Each 
film specimen is weighed and placed in a preweighed stainless steel 
wire mesh. The mesh containing film specimen is immersed into 15 
ml simulated saliva solution in a container. Increase in the weight of 
the film is observed at the preset interval until a constant weight is 
observed [25].  
The degree of swelling was calculated using;  
α = wt-wo/wo 
Where wt is the weight of film at a time  
t and wo is the weight of film at time zero  
Surface pH of the film 
Surface pH of the film is measured by placing the film on the surface 
of 1.5% w/v agar gel followed by putting pH paper (pH range 1-11) 
on the film. The change of the colour of pH paper was observed and 
recorded. 
Organoleptic evaluation 
For organoleptic assessment of the product, different controlled 
human taste panels are utilized. In vitro methods of using taste 
sensors, especially designed apparatus and drug release assessed by 
modified pharmacopoeial methods. These in vitro taste assessment 
apparatus and techniques are well suited for high-throughput taste 
screening of oral pharmaceutical products [27]. 
Transparency 
The transparency of the film can be determined using a simple UV 
spectrophotometer. Cut the film specimen into a rectangle and 
placed on the internal side of the spectrophotometer cell. The 
transmittance of the film is determined at 600 nm. The transparency 
of the film is calculated as follows:  
Transparency = (logT600)/b =-€c 
Where T600 is transmittance at 600 nm 
b is the film thickness 
c is concentration 
Assay/content uniformity 
Assay or content uniformity is determined by any standard assay 
method described for the active pharmaceutical ingredient in any of 
the standard pharmacopeia. Content consistency is determined by 
estimating the active pharmaceutical content in an individual film of 
content uniformity is 85-115%. 
Moisture content 
The amount of moisture in the film is significant as it influences 
mechanical strength, adhesive properties and friability of the film. 
Various parameters are liable for elevating water levels such as 
hygroscopic properties of an active pharmaceutical ingredient, 
polymers and solvent system used to solubilize the polymeric 
mixture, and manufacturing methods. The moisture content of the 
film is measured by several techniques such as Karl Fischer titration 
or by weighing way [27].  
Moisture content = [Initial weight–Final dried weight/Initial weight] 
* 100 
Disintegration time 
The disintegration of oral films requires USP disintegration 
apparatus. The disintegration time limit of 30 seconds or less for 
Umashankar et al. 
Int J App Pharm, Vol 10, Issue 6, 2018, 27-33 
 
31 
orally disintegrating tablets described in the Center for Drug 
Evaluation and Research (CDER) guidance can be applied to oral 
films. Disintegration time will vary depending on the formulation 
but typically the disintegration range from 5 to 30 seconds. There is 
no official guidance available for the disintegration of oral films. 
Dissolution test 
Dissolution test can be performed by using the standard basket or 
paddle apparatus described in any of the pharmacopeias. The 
dissolution medium mimicking saliva will be selected as per the sink 
conditions and highest dose of the active pharmaceutical ingredient. 
At times the dissolution test can be difficult due to a tendency of the 
oral film to float onto the dissolution medium when the paddle is 
moving. During the study, the condition of the medium is maintained 
at 37±0.5 degree Celsius and revolution per minute (rpm) at 50 [28]. 
Applications of the oral films 
• Oral administration of a drug by sublingual, buccal and mucosal 
route with the aid of oral films have become a preferential delivery 
approach for treatment requiring speedy drug absorption which 
includes the ones listed to manipulate pain, allergic reactions, sleep, 
and nervous system disorders. 
• Topical applications: The utilization of oral films can be feasible 
in the delivery of an active pharmaceutical ingredient which 
includes analgesic and antimicrobial agents required in the wound 
healing and other applications [1]. 
• Diagnostic devices: Soluble films can be loaded with a chemical 
reagent to permit managed release when exposed to a biological 
fluid or to form isolation barricades for setting apart reagents to 
modify a time reaction at intervals within a diagnostic device. 
• Vaginal drug delivery system: Films which are meant for vaginal 
administration can be applied physically without untidiness or 
inconvenience of gel or cream application. On contact with the 
vaginal fluid, the film forming substances hydrates to form the 
hydrogel that functions as the usual vaginal product. 
• Gastro retentive drug delivery system: Soluble films are taken 
into consideration as a dosage form for water-soluble and poorly 
soluble molecules of various molecular weight in film forming 
solution. Dissolution of the film caused by pH or enzyme secretion of 
the gastrointestinal tract and it is potentially utilized for treatment 
of the gastrointestinal disorder [13]. 
Drawbacks in the advancement of oral films  
Technology catalyst gives an idea of the arcade of oral film products 
which is valued at $500 million in 2007 and expected to reach $2 
billion in future [13]. Recently, oral films are the substitute to tablets 
and capsules in the market due to patient's preference. Oral films 
continue to be within commencement stages and can be the prime 
preference of patient in the future. Though various oral films brands 
are present, the market remained limited when compared to the oral 
tablets. Over the counter drugs for pain management and motion 
sickness have been commercialized in the United States market. 
Currently, oral prescription films are approved in three major 
countries which are United States, Japan, and European countries. It 
gives the impression that worth of oral film market will grow 
significantly. 
Presently, vast literature is accessible on the formulation, 
development, and evaluation of oral films but formulator faces 
various difficulties while formulating such dosage forms. Thus it is 
important to discuss such drawbacks which may facilitate in the 
future in the formulation and development of oral films. As these 
drawbacks are directly related to patient compliance, they are given 
preference in formulation and development [29]. 
Some of the drawbacks of the advancement of oral films include:  
• Insolubility of drug. 
• Taste masking of the bitter and nauseous drug. 
• High dose incorporation in the film. 
• Ample time required for drying of the film. 
• Stability of film against temperature and humidity [29]. 
• Co-administration of drugs. 
• Uniformity of dose. 
• Special packaging needed. 
Insolubility of drug 
The rate-limiting factor to urge to the desired concentration of 
medication of orally administered formulation in systemic 
circulation is solubility. Solubility problem is the major challenge for 
the formulation of oral film of BCS class II drugs which have low 
solubility and high permeability. 
Taste masking of bitter and nauseous drug 
Taste masking is obligatory for bitter drugs used in oral films to 
improve patient compliance, especially for the pediatric and 
geriatric group. Taste is the essential factor to be considered in oral 
films as it is directly applied in the buccal cavity and it needs to 
remain intact with oral membrane until it gets soluble with saliva in 
the oral cavity. 
High dose incorporation in the film 
In oral films, a high dose can be incorporated assuming that the area 
of the surface is increased. An area should be increased by 
maintaining a thickness of formulation. Thus it also increases the 
volume of the solution required for formulation as the high dose is 
incorporated due to which it takes more time to get dried. 
Ample time required for drying of a film 
The time required for drying plays a crucial role in oral film 
formulation and also in the rate of production of films in industries. 
For oral films of thermosensitive drugs hot air oven cannot be used 
for drying thus, they have to be dried at room temperature. This 
process is time-consuming and at times may cause various 
contamination problems also. 
Stability of thin film against temperature and humidity 
Oral films consist of about 45% of polymer which is hydrophilic in 
nature. In humid conditions film will absorb moisture and gets 
softened due to the dissolution of a film in water. Amorphous drugs 
have higher dissolution rates than crystalline forms but lack of 
physical stability during storage. The best method to prevent the 
drug from crystallization is to add crystallizing inhibitors like 
hydrophilic polymers to the amorphous drugs. 
Co-administration of drugs 
In oral films utilizing more than one drug, i.e. co-administration of 
drugs is a challenging task. It affects the disintegration and 
dissolution time. Co-administration of the drug may also create 
problems like incompatibility, stability etc. 
Uniformity of dose 
Oral films which are meant for administration had to be cut into the 
desired shape, area and required a dose of medication. To get the 
uniformity of dose, it is important to cut into the desired area. This is 
a difficult task in the production and evaluation of oral films. 
The special packaging needed 
It is a crucial job to select the packaging material in the 
pharmaceutical industry to maintain the integrity of the product. 
There are various packaging options available for the oral films. 
Most commonly used packaging material is an aluminum pouch. 
Other materials used are polyester or suitable paper backed 
packaging or cassette packaging. These packaging cause storage and 
stability issues during the usage of the product. 
Market potential  
The understanding of the market potential of oral films is essential 
with an industrial point of view to ensure its future growth. As per the 
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market projection study for 2015-2025, owns a good perspective of 
growth as an upcoming technology of drug delivery. Ten oral films are 
in the market, and twenty-nine are in the stage of various clinical and 
preclinical trails out of which six products were launched in 2016. 
Around to proprietary technologies like Pharm Film, Rapid Film, Bio-
FX, etc. are coming up which has 38% market. Thus it is a potential 
ground for research and idea of the demand for drug products as oral 
films is expected to be worth US$ 15,984.3 million by the end of 2024. 
The worldwide market is estimated to exhibit a compound annual 
growth rate (CAGR) of 9.0% with a significant increase of compound 
annual growth rate (CAGR) of 18.3% between 2016-2024. North 
America is having a leading market share of 85.3%. 
Targeting of drugs is yet to be covered under this technology. The 
oral prescription films currently available in the market are 10. 
About 29 films are in preclinical and clinical developmental stages. 
About 54% of products are oral transmucosal films. By sublingual, 
buccal or oral mucosal route these films can be administered, 
providing an advantage of rapid onset of action. Some of these 
products (approx. 38%) depend on MonoSol's PharmFilm 
innovation or Applied Pharma research/labtec Rapid Film 
innovation. In count to these two, there are over ten other 
proprietary oral thin film technologies, some of these are currently 
being utilized for formulating over-the-counter products. The 
trending OTC drug products are Gas X and Listerine breath 
freshener. Some of the new businesses like Cynapsus Therapeutics 
and FFT Medicals have currently developed, and these new 
upcoming establishments with their oral transmucosal film products 
are probably going to foster more advancement in the coming 
couple of years. Of all the showcased products, Suboxone film has 
obtained acceptance in a short period; other products such as 
Breakyl, Onsolis, and Zuplenz are also progressing in various 
topographies. Even India is concentrating on film technology due to 
which within a short span new companies have emerged such as 
Aavishkar Pvt. Ltd and NU therapeutics in Hyderabad while ZYM 
laboratories in Nagpur. 
The extensive literature survey is mostly based on patents of various 
oral films from multiple patents bodies across the world such as the 
United States Patent and Trademark Office (USPTO), World 
Intellectual Property Right Organization (WIPO), European patent 
office (EPO) and Indian Patent Office (IPO) [18]. The maximum patent 
filling was found in the United States Patent and Trademark Office 
(USPTO) of drugs such as sildenafil citrate, dextromethorphan, 
acetaminophen, buprenorphine and naloxone. India has also 
established in the market for oral films as pharmaceutical companies 
such as MonoSol Rx, Warner-Lambert and Lts Lohmann have filed 
patents in Indian Patent Office (IPO). The key players in the oral film 
market are MonoSol Rx, Applied pharma research/labtec, Pfizer, 
Novartis AG, Wolters Kluwer, Solvay and Allergen [30, 31]. 
There are still various oral films under development such as 
Montelukast which is used for the treatment of asthma and allergy, 
and Rizatriptan which is used for the treatment of migraine is 
developed as a film by MonoSol Rx. Moreover, MonoSol Rx is 
formulating a testosterone film based therapeutic for the treatment 
of male hypogonadism and the product is present in Phase-I. Also, 
Midatech, organization expertise is nanotechnology is joining hands 
with MonoSol Rx to formulate film-based insulin. (Sach Associates, 
5th
 
 annual European Life Science CEP Forum for partnering and 
Investing, March 6-7, 2012, Zurich, Switzerland,). Undergraduate 
biomedical engineering students of Johns Hopkins University have 
formulated a new oral film used as breath revitalizer. Bound with 
the antibody against Rotavirus the strips can be utilized to give the 
immunization to infants or newborn children in ruined areas [32]. 
Thus it can be concluded that there is an exponential increase in 
research in the field of oral films which will substantially influence 
the pharmaceutical market in the future. 
Some patented oral films 
Table 4: Some patented oral films 
Country Patent number Title Inventors Reference 
US 20110305768A1 Quick dissolving oral thin film for 
targeted delivery of therapeutic agents 
Hai-Quan Mao et al.  
WO 2012103464A2 Oral thin film vaccine preparation Brian Pulliam  
US 5948430 Water-soluble film for oral 
administration with instant wettability 
Zerbe et al. 5 
WO 2013085224A1 Bitter taste masked oral thin film 
formulation of Sildenafil citrate 
Dae-Kun Song et al.  
EP 1680079A2 Rapidly disintegrating films for delivery 
of pharmaceutical and cosmetic agents 
Scott D Bamhart et al.  
EP 2509631A4 pH-sensitive compounds in taste 
masking within oral thin films strips 
A Mark Schobel et al.  
WO 2012053006A2 Improved oral fast dissolving films 
comprising a combination of polymers 
and method of preparation thereof 
Rajesh Jain et al.  
US 6596298B2 Fast dissolving orally consumable films Sau-Hung Spence Leung 
et al. 
 
WO 2014183054A1 The thin film with a high load of active 
ingredient 
Eric Allen et al.  
US 7579019B2 Pharmaceutical carrier device suitable 
for the delivery of pharmaceutical 
compounds to the mucosal surface 
Tapolsky et al.  
US 6159498 Bioerodable film for delivery of 
pharmaceutical compounds of the 
mucosal surface 
Tapolsky et al.  
US 6824829B2 Process for manufacturing thin film strip Berry et al.  
US 7132113B2 Flavoured film Zerbe et al.  
US 7182964B2 Dissolving thin film xanthone 
supplement 
Kupper et al.  
US 7241411B2 Thin film strip Berry et al.  
US 7267718B2 Pullulan film composition Scott et al.  
US 7347985B2 Breath freshening and oral cleansing 
product with a magnolia bark extract 
Maxwell et al. 21 
US 1648712B2 A fast dissolving orally consumable film 
containing taste masking agent 
Bess et al. 33 
Umashankar et al. 




Oral films have currently gained a lot of consideration as a non-
obstructive route of drug delivery. Although most of the 
formulations today are oral disintegrating tablets, oral films are 
found more attractive due to easy portability, enhanced patient 
compliance and simple administration. Apart from using them as 
medicament films, they can also be used as refreshing mouth films, 
nutritional supplements, etc. They own many advantages over 
conventional dosage form. Oral drug delivery system is getting 
sophisticated day by day to provide better compliance and efficiency 
in which oral films are capturing a market and challenging 
pharmaceutical companies for developing oral films for a wide range 
of drugs. The key aspects for worldwide oral film market are up 
surging demand of oral films, significant research, and development 
in the segment, low advancement cost when contrasted with new 
medications and strategic coalitions with novel innovation 
proprietors and pharmaceutical titans. This unique technology is 
found to be flourishing up in the Indian market as well as 
international market with billion dollar market profiting with the 
equal emergence in pharmaceutical, food and confectionery sectors. 
Promising drug delivery for coming decades and can prove to be a 
better alternative for conventional dosage forms in the future.  
ABBREVIATIONS 
API= active pharmaceutical ingredient, BCS= biopharmaceutical 
classification system, CAGR= compound annual growth rate, CDER= 
Center for Drug Evaluation and Research, EPO= European patent 
office, FDandC= food, drug, and cosmetic, IPO= Indian Patent Office, 
HME= hot melt extrusion, USPTO= United States Patent and 
Trademark Office. 
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